000305470 001__ 305470
000305470 005__ 20251026023427.0
000305470 0247_ $$2doi$$a10.1007/s00330-025-11880-y
000305470 0247_ $$2pmid$$apmid:41117823
000305470 0247_ $$2ISSN$$a0938-7994
000305470 0247_ $$2ISSN$$a1432-1084
000305470 0247_ $$2ISSN$$a1613-3749
000305470 0247_ $$2ISSN$$a1613-3757
000305470 0247_ $$2ISSN$$a(ISSN
000305470 0247_ $$2ISSN$$aDES
000305470 0247_ $$2ISSN$$aSUPPLEMENTS)
000305470 0247_ $$2altmetric$$aaltmetric:182741232
000305470 037__ $$aDKFZ-2025-02186
000305470 041__ $$aEnglish
000305470 082__ $$a610
000305470 1001_ $$0P:(DE-He78)90780180db1ef4845433057cef4eaeb0$$aKeymling, Myriam$$b0$$eFirst author$$udkfz
000305470 245__ $$aOptimizing whole-body MRI for early cancer detection in Li-Fraumeni syndrome: a prospective bicentric study.
000305470 260__ $$aHeidelberg$$bSpringer$$c2025
000305470 3367_ $$2DRIVER$$aarticle
000305470 3367_ $$2DataCite$$aOutput Types/Journal article
000305470 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1761142554_2009042
000305470 3367_ $$2BibTeX$$aARTICLE
000305470 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305470 3367_ $$00$$2EndNote$$aJournal Article
000305470 500__ $$a#EA:E010#LA:E010# / epub
000305470 520__ $$aAnnual whole-body MRI (WB-MRI) is recommended for early cancer detection in individuals with Li-Fraumeni syndrome (LFS). However, there is no agreement on a standardized MRI protocol. This study evaluated the diagnostic performance of different MRI sequences to suggest an optimized protocol for LFS surveillance.In this prospective bicentric study, 113 participants with LFS underwent annual WB-MRI and were included in the analysis. The protocol comprised turbo-spin echo (TSE) T1-weighted and inversion-recovery T2-weighted (TIRM) images of the whole body in coronal orientation, and T2-weighted (HASTE), diffusion-weighted (DWI), and T1-weighted DIXON images (pre- and post-contrast agent administration) from head to thighs in axial orientation. An additional fluid-attenuated inversion recovery (FLAIR) sequence imaged the skull only. Initial clinical interpretation was conducted by staff radiologists. The visibility of reported mass lesions was independently graded in all sequences by three experienced radiologists using a Likert scale. Sequence combinations were compared to inform the design of an optimal MRI protocol.Over 30 months, 189 WB-MRI examinations were performed in 113 participants (mean age 40 years, ±12.7 years [standard deviation], 91 women). 188 mass lesions were detected and confirmed as malignant (n = 38), benign (n = 120) or ambiguous (n = 30). In the multi-reader analysis, all new malignant lesions could have been detected by a combination of cranial FLAIR, whole-body DWI, and whole-body HASTE in the axial direction.A shortened, contrast-agent-free WB-MRI protocol combining cranial FLAIR, WB-HASTE, and WB-DWI promises to be an effective and patient-friendly approach for annual cancer surveillance in LFS.Question Annual whole-body MRI (WB-MRI) is recommended for early cancer detection for individuals with Li-Fraumeni syndrome (LFS), but a standardized sequence protocol has yet to be established. Findings The combination of cranial FLAIR, whole-body HASTE, and whole-body DWI in the axial plane enabled visualization of all newly developed malignant lesions in our study cohort. Clinical relevance A shortened, standardized WB-MRI protocol enables efficient, sensitive early cancer detection in individuals with LFS, minimizing patient burden by reducing examination time and contrast agent use. This approach may improve surveillance participation while enhancing comparability across centers.
000305470 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000305470 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305470 650_7 $$2Other$$aLi-Fraumeni syndrome
000305470 650_7 $$2Other$$aMagnetic resonance imaging
000305470 650_7 $$2Other$$aProtocol optimization
000305470 650_7 $$2Other$$aSurveillance
000305470 650_7 $$2Other$$aWhole-body
000305470 7001_ $$0P:(DE-He78)ea7f20e71e3cb1a864c23f2f09f0b0b9$$aKurz, Felix Tobias$$b1$$udkfz
000305470 7001_ $$0P:(DE-He78)59dfdd0ee0a7f0db81535f0781a3a6d6$$aKuder, Tristan Anselm$$b2$$udkfz
000305470 7001_ $$aBickelhaupt, Sebastian$$b3
000305470 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b4$$udkfz
000305470 7001_ $$0P:(DE-He78)23a9714c3fa8990e4c253d71fe417590$$aHog, Robert$$b5
000305470 7001_ $$aMokry, Theresa$$b6
000305470 7001_ $$aAlsady, Tawfik Moher$$b7
000305470 7001_ $$aSchott, Sarah$$b8
000305470 7001_ $$aKratz, Christian$$b9
000305470 7001_ $$aRenz, Diane Miriam$$b10
000305470 7001_ $$0P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aSchlemmer, Heinz-Peter$$b11$$eLast author$$udkfz
000305470 773__ $$0PERI:(DE-600)1472718-3$$a10.1007/s00330-025-11880-y$$pnn$$tEuropean radiology$$vnn$$x0938-7994$$y2025
000305470 909CO $$ooai:inrepo02.dkfz.de:305470$$pVDB
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90780180db1ef4845433057cef4eaeb0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ea7f20e71e3cb1a864c23f2f09f0b0b9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)59dfdd0ee0a7f0db81535f0781a3a6d6$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)23a9714c3fa8990e4c253d71fe417590$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000305470 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000305470 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000305470 9141_ $$y2025
000305470 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-28$$wger
000305470 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-28$$wger
000305470 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR RADIOL : 2022$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-28
000305470 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR RADIOL : 2022$$d2024-12-28
000305470 9202_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000305470 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000305470 9201_ $$0I:(DE-He78)E020-20160331$$kE020$$lE020 Med. Physik in der Radiologie$$x1
000305470 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x2
000305470 9200_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000305470 980__ $$ajournal
000305470 980__ $$aVDB
000305470 980__ $$aI:(DE-He78)E010-20160331
000305470 980__ $$aI:(DE-He78)E020-20160331
000305470 980__ $$aI:(DE-He78)C060-20160331
000305470 980__ $$aUNRESTRICTED